Urinary Tract Infections

Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases

Volumn 1, Issue , 2014, Pages 886-913.e3

  Sobel, Jack D ^a   Kaye, Donald ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Bacteriuria; Bladder; Candiduria; Cystitis; Infection; Kidney; Pyelonephritis; Reinfection; Relapse; Urinary

Indexed keywords

EID: 84944614494     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4557-4801-3.00074-6     Document Type: Chapter

References (292)

1. Levison ME, Kaye D Treatment of complicated urinary tract infections with an emphasis on drug-resistant gram-negative uropathogens. Curr Infect Dis Rep 2013, 15:109-115.
2. Nicolle L Complicated urinary tract infection in adults. Can J Infect Dis Med Microbiol 2005, 16:349-360.
3. Alpers CE The kidney. Robbins and Cotran Pathologic Basis of Disease 2010, 905-969. Elsevier-Saunders, Philadelphia. 8th ed. V. Kumar, A.K. Abbas, N. Fausto, J.C. Aster (Eds.).
4. Turck M, Goffe B, Petersdorf RG The urethral catheter and urinary tract infection. J Urol 1962, 88:834-837.
5. Hooton TM, Scholes D, Hughes JP, et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 1996, 335:468-474.
6. Raz R, Gennesin Y, Wasser J, et al. Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis 2000, 30:152-156.
7. Moore EE, Hawes SE, Scholes D, et al. Sexual intercourse and risk of symptomatic urinary tract infection in post-menopausal women. J Gen Intern Med 2008, 23:595-599.
8. Plos K, Connell H, Jodal U, et al. Intestinal carriage of P fimbriated Escherichia coli and the susceptibility to urinary tract infection in young children. J Infect Dis 1995, 171:625-631.
9. Measley RE, Levison ME Host defense mechanisms in the pathogenesis of urinary tract infection. Med Clin North Am 1991, 75:275-286.
10. Manges AR, Dietrich PS, Riley LW Multidrug-resistant Escherichia coli clonal groups causing community-acquired pyelonephritis. Clin Infect Dis 2004, 38:329-334.
11. Johnson JR, Orskov I, Orskov F, et al. O, K, and H antigens predict virulence factors, carboxylesterase B pattern, antimicrobial resistance, and host compromise among Escherichia coli strains causing urosepsis. J Infect Dis 1994, 169:119-126.
12. Johnson JR, Kuskowski MA, Gajewski A, et al. Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis. J Infect Dis 2005, 191:46-50.
13. Hilbert DW, Paulish-Miller TE, Tan CK, et al. Clinical Escherichia coli isolates utilize alpha-hemolysin to inhibit in vitro epithelial cytokine production. Microbes Infect 2012, 14:628-638.
14. Bahrani-Mougeot FK, Buckles EL, Lockatell CV, et al. Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract. Mol Microbiol 2002, 45:1079-1093.
15. Hacker J, Kaper JB Pathogenicity islands and the evolution of microbes. Annu Rev Microbiol 2000, 54:641-679.
16. Bidet P, Bonacorsi S, Clermont O, et al. Multiple insertional events, restricted by the genetic background, have led to acquisition of pathogenicity island IIJ96-like domains among Escherichia coli strains of different clinical origins. Infect Immun 2005, 73:4081-4087.
17. Bauer RJ, Zhang L, Foxman B, et al. Molecular epidemiology of 3 putative virulence genes for Escherichia coli urinary tract infection-usp, iha, and iroN (E. coli). J Infect Dis 2002, 185:1521-1524.
18. Hull RA, Hull SI Nutritional requirements for growth of uropathogenic Escherichia coli in human urine. Infect Immun 1997, 65:1960-1961.
19. Spurbeck RR, Stapleton AE, Johnson JR, et al. Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: contribution of ygi and yad fimbriae. Infect Immun 2011, 79:4753-4763.
20. Wullt B, Bergsten G, Samuelsson M, et al. The role of P fimbriae for colonization and host response induction in the human urinary tract. J Infect Dis 2001, 183(suppl 1):S43-S46.
21. Otto G, Magnusson M, Svensson M, et al. Pap genotype and P fimbrial expression in Escherichia coli causing bacteremic and nonbacteremic febrile urinary tract infection. Clin Infect Dis 2001, 32:1523-1531.
22. Johnson JR, Russo TA, Brown JJ, et al. papG alleles of Escherichia coli strains causing first-episode or recurrent acute cystitis in adult women. J Infect Dis 1998, 177:97-101.
23. Bergsten G, Samuelsson M, Wullt B, et al. PapG-dependent adherence breaks mucosal inertia and triggers the innate host response. J Infect Dis 2004, 189:1734-1742.
24. Hedges SR, Agace WW, Svanborg C Epithelial cytokine responses and mucosal cytokine networks. Trends Microbiol 1995, 3:266-270.
25. Loughman JA, Hunstad DA Attenuation of human neutrophil migration and function by uropathogenic bacteria. Microbes Infect 2011, 13:555-565.
26. Wu XR, Sun TT, Medina JJ In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections. Proc Natl Acad Sci U S A 1996, 93:9630-9635.
27. Zhou G, Mo WJ, Sebbel P, et al. Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding. J Cell Sci 2001, 114:4095-4103.
28. Sokurenko EV, Chesnokova V, Dykhuizen DE, et al. Pathogenic adaptation of Escherichia coli by natural variation of the FimH adhesin. Proc Natl Acad Sci U S A 1998, 95:8922-8926.
29. Schembri MA, Hasman H, Klemm P Expression and purification of the mannose recognition domain of the FimH adhesin. FEMS Microbiol Lett 2000, 188:147-151.
30. Holden NJ, Totsika M, Mahler E, et al. Demonstration of regulatory cross-talk between P fimbriae and type 1 fimbriae in uropathogenic Escherichia coli. Microbiology 2006, 152:1143-1153.
31. Ong CL, Ulett GC, Mabbett AN, et al. Identification of type 3 fimbriae in uropathogenic Escherichia coli reveals a role in biofilm formation. J Bacteriol 2008, 190:1054-1063.
32. Nowicki B, Selvarangan R, Nowicki S Family of Escherichia coli Dr adhesins: decay-accelerating factor receptor recognition and invasiveness. J Infect Dis 2001, 183(suppl 1):S24-S27.
33. Das M, Hart-Van Tassell A, Urvil PT, et al. Hydrophilic domain II of Escherichia coli Dr fimbriae facilitates cell invasion. Infect Immun 2005, 73:6119-6126.
34. Barber AE, Norton JP, Spivak AM, et al. Urinary tract infections: current and emerging management strategies. Clin Infect Dis 2013, 57:719-724.
35. Johnson JR, Scheutz F, Ulleryd P, et al. Host-pathogen relationships among Escherichia coli isolates recovered from men with febrile urinary tract infection. Clin Infect Dis 2005, 40:813-822.
36. Vila J, Simon K, Ruiz J, et al. Are quinolone-resistant uropathogenic Escherichia coli less virulent?. J Infect Dis 2002, 186:1039-1042.
37. Floyd RV, Upton M, Hultgren SJ, et al. Escherichia coli-mediated impairment of ureteric contractility is uropathogenic E. coli specific. J Infect Dis 2012, 206:1589-1596.
38. Davis JM, Rasmussen SB, O'Brien AD Cytotoxic necrotizing factor type 1 production by uropathogenic Escherichia coli modulates polymorphonuclear leukocyte function. Infect Immun 2005, 73:5301-5310.
39. Johnson JR, Jelacic S, Schoening LM, et al. The IrgA homologue adhesin Iha is an Escherichia coli virulence factor in murine urinary tract infection. Infect Immun 2005, 73:965-971.
40. Zdziarski J, Svanborg C, Wullt B, et al. Molecular basis of commensalism in the urinary tract: low virulence or virulence attenuation?. Infect Immun 2008, 76:695-703.
41. Nielubowicz GR, Mobley HL Host-pathogen interactions in urinary tract infection. Nat Rev Urol 2010, 7:430-441.
42. Ragnarsdóttir B, Jönsson K, Urbano A, et al. Toll-like receptor 4 promoter polymorphisms: common TLR4 variants may protect against severe urinary tract infection. PLoS One 2010, 5:e10734.
43. Hernández JG, Sundén F, Connolly J, et al. Genetic control of the variable innate immune response to asymptomatic bacteriuria. PLoS One 2011, 6:e28289.
44. Svanborg C, Frendeus B, Godaly G, et al. Toll-like receptor signaling and chemokine receptor expression influence the severity of urinary tract infection. J Infect Dis 2001, 183(suppl 1):S61-S65.
45. Hawn TR, Scholes D, Li SS, et al. Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women. PLoS One 2009, 4:e5990.
46. Otto G, Braconier J, Andreasson A, et al. Interleukin-6 and disease severity in patients with bacteremic and nonbacteremic febrile urinary tract infection. J Infect Dis 1999, 179:172-179.
47. Godaly G, Hang L, Frendeus B, et al. Transepithelial neutrophil migration is CXCR1 dependent in vitro and is defective in IL-8 receptor knockout mice. J Immunol 2000, 165:5287-5294.
48. Frendéus B, Wachtler C, Hedlund M, et al. Escherichia coli P fimbriae utilize the Toll-like receptor 4 pathway for cell activation. Mol Microbiol 2001, 40:37-51.
49. Ragnarsdóttir B, Samuelsson M, Gustafsson MC, et al. Reduced toll-like receptor 4 expression in children with asymptomatic bacteriuria. J Infect Dis 2007, 196:475-484.
50. Billips BK, Forrestal SG, Rycyk MT, et al. Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli. Infect Immun 2007, 75:5353-5360.
51. Ragnarsdóttir B, Svanborg C Susceptibility to acute pyelonephritis or asymptomatic bacteriuria: host-pathogen interaction in urinary tract infections. Pediatr Nephrol 2012, 27:2017-2029.
52. Ali AS, Townes CL, Hall J, et al. Maintaining a sterile urinary tract: the role of antimicrobial peptides. J Urol 2009, 182:21-28.
53. Scherberich JE, Hartinger A Impact of Toll-like receptor signalling on urinary tract infection. Int J Antimicrob Agents 2008, 31:S9-S14.
54. Stamey TA The role of introital enterobacteria in recurrent urinary infections. J Urol 1973, 109:467-472.
55. Czaja CA, Stamm WE, Stapleton AE, et al. Prospective cohort study of microbial and inflammatory events immediately preceding Escherichia coli recurrent urinary tract infection in women. J Infect Dis 2009, 200:528-536.
56. Scholes D, Hooton TM, Roberts PL, et al. Risk factors for recurrent urinary tract infection in young women. J Infect Dis 2000, 182:1177-1182.
57. Stapleton A Host factors in susceptibility to urinary tract infections. Adv Exp Med Biol 1999, 462:351-358.
58. McGroarty FA, Chong S, Reid G Influence of the spermicidal compund nonoxynol-9 on the growth and adhesion of urogenital bacterial in vitro. Curr Microbiol 1990, 21:219-223.
59. Foxman B, Gillespie B, Koopman J, et al. Risk factors for second urinary tract infection among college women. Am J Epidemiol 2000, 151:1194-1205.
60. Svanborg-Eden C, Svennerholm AM Secretory immunoglobulin A and G antibodies prevent adhesion of Escherichia coli to human urinary tract epithelial cells. Infect Immun 1978, 22:790-797.
61. Vroom TM, Scholte G, Ossendorp F, et al. Tissue distribution of human gamma delta T cells: no evidence for general epithelial tropism. J Clin Pathol 1991, 44:1012-1017.
62. Park JC, Buono D, Smith DK, et al. Urinary tract infections in women with or at risk for human immunodeficiency virus infection. Am J Obstet Gynecol 2002, 187:581-588.
63. Rajan N, Cao Q, Anderson BE, et al. Roles of glycoproteins and oligosaccharides found in human vaginal fluid in bacterial adherence. Infect Immun 1999, 67:5027-5032.
64. Lundstedt AC, McCarthy S, Gustafsson MC, et al. A genetic basis of susceptibility to acute pyelonephritis. PLoS One 2007, 2:e825.
65. Scholes D, Hawn TR, Roberts PL, et al. Family history and risk of recurrent cystitis and pyelonephritis in women. J Urol 2010, 184:564-569.
66. Stauffer CM, van der Weg B, Donadini R, et al. Family history and behavioral abnormalities in girls with recurrent urinary tract infections: a controlled study. J Urol 2004, 171:1663-1665.
67. Smithson A, Sarrias MR, Barcelo J, et al. Expression of interleukin-8 receptors (CXCR1 and CXCR2) in premenopausal women with recurrent urinary tract infections. Clin Diagn Lab Immunol 2005, 12:1358-1363.
68. Barton GM, Medzhitov R Toll-like receptor signaling pathways. Science 2003, 300:1524-1525.
69. Bates JM, Raffi HM, Prasadan K, et al. Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication. Kidney Int 2004, 65:791-797.
70. Nicolle LE Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis. Urol Clin North Am 2008, 35:1-12.
71. Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011, 52:e103-e120.
72. Gaynes R, Edwards JR National Nosocomial Infections Surveillance System. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005, 41:848-854.
73. Wagenlehner FM, Krcmery S, Held C, et al. Epidemiological analysis of the spread of pathogens from a urological ward using genotypic, phenotypic and clinical parameters. Int J Antimicrob Agents 2002, 19:583-591.
74. Lopez-Medrano F, Garcia-Bravo M, Morales JM, et al. Urinary tract infection due to Corynebacterium urealyticum in kidney transplant recipients: an underdiagnosed etiology for obstructive uropathy and graft dysfunction-results of a prospective cohort study. Clin Infect Dis 2008, 46:825-830.
75. Soriano F, Tauch A Microbiological and clinical features of Corynebacterium urealyticum: urinary tract stones and genomics as the Rosetta Stone. Clin Microbiol Infect 2008, 14:632-643.
76. Centers for Disease Control and Prevention Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR 2009, 58:256-260.
77. Kumarasamy KK, Tolman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010, 10:597-602.
78. Centers for Disease Control and Prevention Carbapenem-resistant Enterobacteriaceae containing New Delhi metallo-beta-lactamase in two patients-Rhode Island, March 2012. MMWR 2012, 61:446-448.
79. Falagas ME, Kastoris AC, Kapaskelis AM, et al. Fosfomcyin for the treatment of multidrug resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect Dis 2010, 10:43-50.
80. Peirano G, Pitout JD Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 2010, 35:316-321.
81. Rodríguez-Baño J, Navarro MD Extended-spectrum beta-lactamases in ambulatory care: a clinical perspective. Clin Microbiol Infect 2008, 14(suppl 1):104-110.
82. Johnson JR, Johnston B, Connie C, et al. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis 2010, 51:286-294.
83. Malani AN, Kauffman CA Candida urinary tract infections: treatment options. Expert Rev Anti Infect Ther 2007, 5:277-284.
84. Kauffman CA, Fisher JF, Sobel JD, et al. Candida urinary tract infections-diagnosis. Clin Infect Dis 2011, 52(suppl 6):S452-S456.
85. Raz R, Colodner R, Kunin CM Who are you-Staphylococcus saprophyticus?. Clin Infect Dis 2005, 40:896-898.
86. Cattoir V Actinobaculum schaalii: review of an emerging pathogen. J Infect 2012, 64:260-267.
87. Gomez R, Gustafson DR, Rosenblagt JR, Patel R Actinobaculum bacteremia: a report of 12 cases. J Clin Microbiol 2011, 49:4311-4313.
88. Zimmerman P, Berlinger L, Liniger B, et al. Actinobaculum schaalii an emerging pediatric pathogen?. BMC Infect Dis 2012, 12:201-216.
89. Akiyama H, Kurosu T, Sakashita C, et al. Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation. Clin Infect Dis 2001, 32:1325-1330.
90. Kajander EO, Ciftcioglu N Nanobacteria: an alternative mechanism for pathogenic intra-and extracellular calcification and stone formation. Proc Natl Acad Sci U S A 1998, 95:8274-8279.
91. Raoult D, Drancourt M, Azza S, et al. Nanobacteria are mineralo fetuin complexes. PLoS Pathog 2008, 4:e41.
92. Kumon H, Matsumoto A, Uehara S, et al. Detection and isolation of nanobacteria-like particles from urinary stones: long-withheld data. Int J Urol 2011, 18:458-465.
93. Lin K, Fajardo K Screening for asymptomatic bacteriuria in adults: evidence for the U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med 2008, 149:W20-W24. U.S. Preventive Services Task Force.
94. Ma JF, Shortliffe LM Urinary tract infection in children: etiology and epidemiology. Urol Clin North Am 2004, 31:517-526.
95. Zorc JJ, Kiddoo DA, Shaw KN Diagnosis and management of pediatric urinary tract infections. Clin Micro Rev 2005, 18:417-422.
96. Montini G, Tullus K, Hewitt I Febrile urinary tract infections in children. N Engl J Med 2011, 365:239-250.
97. Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. American Academy of Pediatrics Committee on Quality Improvement. Subcommittee on Urinary Tract Infection. Pediatrics 1999, 103:843-852.
98. Shaikh N, Morone NE, Lopez J, et al. Does this child have a urinary tract infection?. JAMA 2007, 298:2895-2904.
99. Morris BJ, Waskett JH, Banerjee J A 'snip' in time: what is the best age to circumcise?. BMC Pediatr 2012, 12:20.
100. Saadeh SA, Mattoo TK Managing urinary tract infections. Pediatr Nephrol 2011, 26:1967-1976.
101. Smellie JM, Prescod NP, Shaw PJ, et al. Childhood reflux and urinary infection: a follow-up of 10-41 years in 226 adults. Pediatr Nephrol 1998, 12:727-736.
102. Kunin CM Urinary tract infections in children. Hosp Pract 1976, 11:91-98.
103. Gillenwater JY, Harrison RB, Kunin CM Natural history of bacteriuria in schoolgirls. A long-term case-control study. N Engl J Med 1979, 301:396-399.
104. Martinell J, Lidin-Janson G, Jagenburg R, et al. Girls prone to urinary infections followed into adulthood. Indices of renal disease. Pediatr Nephrol 1996, 10:139-142.
105. Schlager TA Urinary tract infections in infants and children. Infect Dis Clin North Am 2003, 17:353-365.
106. Olbing H, Hirche H, Koskimies O, et al. Renal growth in children with severe vesicoureteral reflux: 10-year prospective study of medical and surgical treatment: the International Reflux Study in Children (European branch). Radiology 2000, 216:731-737.
107. Mattoo TK Vesicoureteral reflux and reflux nephropathy. Adv Chronic Kidney Dis 2011, 18:348-354.
108. Shaikh N, Ewing AL, Bhatnagar S, Hoberman A Risk of renal scarring in children with a first urinary tract infection: a systematic review. Pediatrics 2010, 126:1084-1091.
109. Gargollo PC, Diamond DA Therapy insight: what nephrologists need to know about primary vesicoureteral reflux. Nat Clin Pract Neph 2007, 3:551-563.
110. Austin JC, Cooper CS Vesicoureteral reflux: who benefits from correction. Urol Clin North Am 2010, 37:243-252.
111. Ronald AR, Pattullo AL The natural history of urinary infection in adults. Med Clin North Am 1991, 75:299-312.
112. Foxman B Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002, 113(suppl 1A):5S-13S.
113. Nicolle L, Anderson PA, Conly J, et al. Uncomplicated urinary tract infection in women. Can Fam Physician 2006, 52:612-618.
114. Hooton TM Pathogenesis of urinary tract infections: an update. J Antimicrob Chemother 2000, 46(suppl A):1-7.
115. Hooton TM Uncomplicated urinary tract infection. N Engl J Med 2012, 366:1028-1037.
116. Nicolle LE Update in adult urinary tract infection. Curr Infect Dis Rep 2011, 13:552-560.
117. Foxman B The epidemiology of urinary tract infection. Nat Rev Urol 2010, 7:653-660.
118. Nicolle LE Terra incognito: the ureter in urinary tract infection. J infect Dis 2012, 206:1494-1496.
119. Foxman B, Manning SD, Tallman P, et al. Uropathogenic Escherichia coli are more likely than commensal E. coli to be shared between heterosexual sex partners. Am J Epidemiol 2002, 156:1133-1140.
120. Spach DH, Stapleton AE, Stamm WE Lack of circumcision increases the risk of urinary tract infection in young men. JAMA 1992, 267:679-681.
121. Russell DB, Roth NJ Urinary tract infections in men in a primary care population. Aust Fam Physician 2001, 30:177-179.
122. U.S.Department of Health and Human Services (DHHS), National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) United States Renal Data System 2007 Annual Report Available at. http://www.usrds.org/adr.htm.
123. Schechter H, Leonard CD, Scribner BH Chronic pyelonephritis as a cause of renal failure in dialysis candidates. Analysis of 173 patients. JAMA 1971, 216:514-517.
124. Nicolle LE Urinary tract infections in long-term-care facilities. Infect Control Hosp Epidemiol 2001, 22:167-175.
125. Baldassarre JS, Kaye D Special problems of urinary tract infection in the elderly. Med Clin North Am 1991, 75:375-390.
126. Moore EE, Jackson SL, Boyko EJ, et al. Urinary incontinence and urinary tract infection: temporal relationships in postmenopausal women. Obstet Gynecol 2008, 111:317-323.
127. Boscia JA, Abrutyn E, Kaye D Asymptomatic bacteriuria in elderly persons: treat or do not treat?. Ann Intern Med 1987, 106:764-766.
128. Nicolle LE Urinary tract infections in the elderly. Clin Geriatr Med 2009, 25:423-436.
129. Abrutyn E, Mossey J, Berlin JA, et al. Does asymptomatic bacteriuria predict mortality and does antimicrobial treatment reduce mortality in elderly ambulatory women?. Ann Intern Med 1994, 120:827-833.
130. Nicolle L, Bradley S, Colgan R, et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005, 40:643-654.
131. Patterson TF, Andriole VT Detection, significance, and therapy of bacteriuria in pregnancy. Update in the managed health care era. Infect Dis Clin North Am 1997, 11:593-608.
132. Patterson JE, Andriole VT Bacterial urinary tract infections in diabetes. Infect Dis Clin North Am 1997, 11:735-750.
133. Stapleton A Urinary tract infections in patients with diabetes. Am J Med 2002, 113(suppl 1A):80S-84S.
134. Muller LM, Gorter KJ, Hak E, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis 2005, 41:281-288.
135. Nicolle LE, Zhanel GG, Harding GK Microbiological outcomes in women with diabetes and untreated asymptomatic bacteriuria. World J Urol 2006, 24:61-65.
136. Thurman AR, Steed LL, Hulsey T, et al. Bacteriuria in pregnant women with sickle cell trait. Am J Obstet Gynecol 2006, 194:1366-1370.
137. Awolude OA, Adesina OA, Oladokun A, et al. Asymptomatic bacteriuria among HIV positive pregnant women. Virulence 2010, 1:130-133.
138. Shindel AW, Akhavan A, Sharlip ID Urologic aspects of HIV infection. Med Clin North Am 2011, 95:129-151.
139. Brown PD Urinary tract infections in renal transplant recipients. Curr Infect Dis Rep 2002, 4:525-528.
140. Khosroshahi HT, Mogaddam AN, Shoja MM Efficacy of high-dose trimethoprim-sulfamethoxazole prophylaxis on early urinary tract infection after renal transplantation. Transplant Proc 2006, 38:2062-2064.
141. Green H, Rahamimov R, Gafter U, et al. Antibiotic prophylaxis for urinary tract infections in renal transplant recipients: a systematic review and meta-analysis. Transpl Infect Dis 2011, 13:441-447.
142. Alangaden GJ, Thyagarajan R, Gruber SA, et al. Infectious complications after kidney transplantation: current epidemiology and associated risk factors. Clin Transplant 2006, 20:401-409.
143. Juthani-Mehta M Asymptomatic bacteriuria and urinary tract infection in older adults. Clin Geriatr Med 2007, 23:585-594.
144. Gleckman R, Blagg N, Hibert D, et al. Acute pyelonephritis in the elderly. South Med J 1982, 75:551-554.
145. Boscia JA, Kobasa WD, Abrutyn E, et al. Lack of association between bacteriuria and symptoms in the elderly. Am J Med 1986, 81:979-982.
146. Ouslander JG, Schapira M, Schnelle JF, et al. Does eradicating bacteriuria affect the severity of chronic urinary incontinence in nursing home residents?. Ann Intern Med 1995, 122:749-754.
147. Kaye D, Rocha H Urinary concentrating ability in early experimental pyelonephritis. J Clin Invest 1970, 49:1427-1437.
148. Boscia JA, Abrutyn E, Levison ME, et al. Pyuria and asymptomatic bacteriuria in elderly ambulatory women. Ann Intern Med 1989, 110:404-405.
149. Pappas PG Laboratory in the diagnosis and management of urinary tract infections. Med Clin North Am 1991, 75:313-325.
150. Bent S, Saint S The optimal use of diagnostic testing in women with acute uncomplicated cystitis. Am J Med 2002, 113(suppl 1A):20S-28S.
151. Deville WJM, Yzermans JC, van Duijn NP, et al. The urine dipstick test useful to rule out infections. A meta-analysis of the accuracy. BMC Urol 2004, 4:4.
152. St.John A, Boyd JC, Lowes AJ, et al. The use of urinary dipstick tests to exclude urinary tract infection. A systematic review of the literature. Am J Clin Path 2006, 126:428-436.
153. Schmiemann G, Kniehl E, Gebhardt K, et al. The diagnosis of urinary tract infection: a systematic review. Dtsch Arztebl Int 2010, 107:361-367.
154. Rubin RH, Shapiro ED, Andriole VT, et al. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992, 15(suppl 1):S216-S227.
155. Warren JW, Abrutyn E, Hebel JR, et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999, 29:745-758.
156. Lifshitz E, Kramer L Outpatient urine culture: does collection technique matter?. Arch Intern Med 2000, 160:2537-2540.
157. Lau AY, Wong SN, Yip KT A comparative study on bacterial cultures of urine samples obtained by clean-void technique versus urethral catheterization. Acta Paediatr 2007, 96:432-436.
158. Hooton TM, Roberts PL, Cox ME, et al. Voided midstream urine culture and acute cystitis in premenopausal women. N Engl J Med 2013, 369:1883-1891.
159. Hooton TM The current management strategies for community-acquired urinary tract infection. Infect Dis Clin North Am 2003, 17:303-322.
160. Kunin CM, White LV, Hua TH A reassessment of the importance of "low-count" bacteriuria in young women with acute urinary symptoms. Ann Intern Med 1993, 119:454-460.
161. Centers for Disease Control and Prevention Sexually trans-mitted disease treatment guidelines, 2006. MMWR 2006, 55(RR-11):1-94.
162. Fairley KF, Carson NE, Gutch RC, et al. Site of infection in acute urinary tract infection in general practice. Lancet 1971, 2:615-618.
163. Little P, Moore MV, Turner S, et al. Effectiveness of five different approaches in management of urinary tract infection: randomized controlled trial. BMJ 2010, 340:c199.
164. Bleindorn J, Gagyor I, Kochen MM, et al. Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for acute uncomplicated urinary tract infection? Results of a randomized controlled pilot trial. BMC Med 2010, 8:30.
165. Falagas ME, Kotsantis IK, Vouloumanou EK, et al. Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials. J Infect 2009, 58:91-102.
166. Cai T, Mazzoli S, Mondaini F, et al. The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections: to treat or not to treat?. Clin Infect Dis 2012, 55:771-777.
167. Boscia JA, Kaye D Asymptomatic bacteriuria in the elderly. Infect Dis Clin North Am 1987, 1:893-905.
168. Platt R Adverse consequences of asymptomatic urinary tract infections in adults. Am J Med 1987, 82:47-52.
169. Dugoua JJ, Seely D, Perri D, et al. Safety and efficacy of cranberry (Vaccinium macrocarpon) during pregnancy and lactation. Can J Clin Pharmacol 2008, 15:e80-e86.
170. Perrotta C, Aznar M, Mejia R, et al. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev 2008, (2).
171. Jepson RG, Williams G, Craig JC Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2012, (10).
172. Stapleton AE, Au-Yeung M, Hooton TM, et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis 2011, 52:1212-1217.
173. Darouiche RO, Hull RA Bacterial interference for prevention of urinary tract infection. Clin Infect Dis 2012, 55:1400-1407.
174. Stamey TA, Fair WR, Timothy MM, et al. Serum versus urinary antimicrobial concentrations in cure of urinary-tract infections. N Engl J Med 1974, 291:1159-1163.
175. Gilbert DN Urinary tract infections in patients with chronic insufficiency. Clin J Am Soc Nephrol 2006, 1:327-331.
176. Prais D, Straussberg R, Avitzur Y, et al. Bacterial susceptibility to oral antibiotics in community-acquired urinary tract infection. Arch Dis Child 2003, 88:215-218.
177. Karlowsky JA, Kelly LJ, Thornsberry C, et al. Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. Antimicrob Agents Chemother 2002, 46:2540-2545.
178. Karlowsky JA, Thornsberry C, Jones ME, et al. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin. Clin Infect Dis 2003, 36:183-187.
179. Guillermo GV, Master RN, Karlowsky JA, et al. In vitro antimicrobial resistance of urinary Escherichia coli isolates among U.S. outpatients from 2000 to 2010. Antimicrob Agents Chemother 2012, 56:2181-2183.
180. Kahlmeter G, Poulsen HO Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO-SENS study revisited. Int J Antimicrob Agents 2012, 39:45-51.
181. Williams GJ, Hodson EH, Issacs D, et al. Diagnosis and management of urinary tract infection in children. J Paediatr Child Health 2012, 48:296-301.
182. National Institute for Health and Clinical Excellence Urinary Tract Infection in Children 2007, NIC, London. http://guidance.nice.org.uk/CG54.
183. Beetz R, Westenfelder M Antimicrobial therapy of urinary tract infections in children. Int J Antimicrob Agents 2011, 38(suppl):42-50.
184. American Urological Association.Clinical guidelines Available at, Accessed Jan. 11, 2013. http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines.cfm?sub=vur2010.
185. Talan DA, Stamm WE, Hooton TM, et al. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial. JAMA 2000, 283:1583-1590.
186. Peterson J, Kaul S, Khashab M, et al. A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis. Urology 2008, 71:17-22.
187. Falagas ME, Vouloumanou EK, Togias AG, et al. Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials. J Antimicrob Chemother 2010, 65:1862-1877.
188. Pallett A, Hand K Complicated urinary tract infections: practical solutions for the treatment of multiresistant gram-negative bacteria. J Antimicrob Chemother 2010, 65(suppl 3):iii25-iii33.
189. Lichtenberger P, Hooton TM Complicated urinary tract infections. Curr Infect Dis Rep 2008, 10:499-504.
190. Gilbert DN Urinary tract infections in patients with chronic renal insufficiency. Clin J Amer Soc Nephrol 2006, 1:327-331.
191. Wang JM, Lim HK, Pang KK Emphysematous pyelonephritis. Scand J Urol Nephrol 2007, 41:223-229.
192. Ubee SS, McGlynn L, Fordham M Emphysematous pyelonephritis. BJU Int 2011, 107:1474-1478.
193. Olson ES, Cookson BD Do antimicrobials have a role in preventing septicaemia following instrumentation of the urinary tract. J Hosp Infect 2000, 45:85-97.
194. Rudenko N, Dorofeyev A Prevention of recurrent lower urinary tract infections by long-term administration of fosfomycin trometamol. Double blind, randomized, parallel group, placebo controlled study. Arzneimittelforschung 2005, 55:420-427.
195. Gupta K, Hooton TM, Roberts PL, et al. Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women. Ann Intern Med 2001, 135:9-16.
196. Lichtenberger P, Hooton TM Antimicrobial prophylaxis in women with recurrent urinary tract infections. Int J Antimicrob Agents 2011, 38(suppl):36-41.
197. Melekos MD, Asbach HW, Gerharz E, et al. Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women. J Urol 1997, 157:935-939.
198. Albert X, Huertas I, Pereiro I Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev 2004, (3).
199. Williams G, Craig JC Prevention of recurrent urinary tract infection in children. Curr Opin Infect Dis 2009, 22:72-76.
200. Conway PH, Cnaan A, Zaoutis T Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials. JAMA 2007, 298:179-186.
201. Sobel JD, Kauffman CA, McKinsey D, et al. Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis 2000, 30:19-24.
202. Safdar N, Slattery WR, Knasinski V, et al. Predictors and outcomes of candiduria in renal transplant recipients. Clin Infect Dis 2005, 40:1413-1421.
203. Fisher JF, Sobel JD, Kauffman CA, et al. Candida urinary tract infections-treatment. Clin Infect Dis 2011, 6:S457-S466.
204. Nowicki B Urinary tract infection in pregnant women: old dogmas and current concepts regarding pathogenesis. Curr Infect Dis Rep 2002, 4:529-535.
205. Gratacos E, Torres PJ, Vila J, et al. Screening and treatment of asymptomatic bacteriuria in pregnancy prevent pyelonephritis. J Infect Dis 1994, 169:1390-1392.
206. Kass EH Bacteriuria and pyelonephritis of pregnancy. Trans Assoc Am Physicians 1959, 72:257-264.
207. Smaill F Asymptomatic bacteriuria in pregnancy. Best Pract Res Clin Obstet Gynaecol 2007, 21:439-450.
208. Conde-Agudelo A, Villar J, Lindheimer M Maternal infection and risk of preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol 2008, 198:7-22.
209. Farkash E, Weintraub AY, Sergienko R, et al. Acute antepartum pyelonephritis in pregnancy: a critical analysis of risk factors and outcomes. Eur J Obstet Gynecol Reprod Biol 2012, 162:24-27.
210. Guinto VT, De Guia B, Festin MR, et al. Different antibiotic regimens for treating asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev 2010, 8.
211. Schneeberger C, Geerlings SE, Middleton P, et al. Interventions for preventing recurrent urinary tract infection during pregnancy. Cochrane Database Syst Rev 2012, (11).
212. Hart A, Nowicki BJ, Reisner B, et al. Ampicillin-resistant Escherichia coli in gestational pyelonephritis: increased occurrence and association with the colonization factor Dr adhesin. J Infect Dis 2001, 183:1526-1529.
213. Thorley JD, Jones SR, Sanford JP Perinephric abscess. Medicine (Baltimore) 1974, 53:441-451.
214. Gardiner RA, Gwynne RA, Roberts SA Perinephric abscess. BJU Int 2011, 3:20-23.
215. Mokabberi R, Ravakhah K Emphysematous urinary tract infections: diagnosis, treatment and survival (case review series). Am J Med Sci 2007, 333:111-116.
216. Brown PS, Dodson M, Weintrub PS Xanthogranulomatous pyelonephritis: report of nonsurgical management of a case and review of the literature. Clin Infect Dis 1996, 22:308-314.
217. Rajesh A, Jakanani G, Mayer N, et al. Computed tomography findings in xanthogranulomatous pyelonephritis. J Clin Imaging Sci 2011, 1:45.
218. Kaplan DM, Rosenfield AT, Smith RC Advances in the imaging of renal infection. Helical CT and modern coordinated imaging. Infect Dis Clin North Am 1997, 11:681-705.
219. Gerzof SG, Gale ME Computed tomography and ultra-sonography for diagnosis and treatment of renal and retroperitoneal abscesses. Urol Clin North Am 1982, 9:185-193.
220. Huligowska E, Newman B, White S Interventional ultrasound in detection and treatment of renal inflammatory disease. Radiology 1983, 147:521-526.
221. Bergeron MG Treatment of pyelonephritis in adults. Med Clin North Am 1995, 79:619-649.
222. Schwab SJ, Bander SJ, Klahr S Renal infection in autosomal dominant polycystic kidney disease. Am J Med 1987, 82:714-718.
223. Siegel JF, Smith A, Moldwin R Minimally invasive treatment of renal abscess. J Urol 1996, 155:52-55.
224. Johnson JR, Vincent LM, Wang K, et al. Renal ultrasonographic correlates of acute pyelonephritis. Clin Infect Dis 1992, 14:15-22.
225. McNicholas MM, Griffin JF, Cantwell DF Ultrasound of the pelvis and renal tract combined with a plain film of abdomen in young women with urinary tract infection: can it replace intravenous urography? A prospective study. Br J Radiol 1991, 64:221-224.
226. Sandler CM, Amis ES, Bigongiari LR, et al. Imaging in acute pyelonephritis. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000, 215(suppl):677-681.
227. Craig WD, Wagner BJ, Travis MD Pyelonephritis: radiologic-pathologic review. Radiographics 2008, 28:255-277.
228. Papanicolaou N, Pfister RC Acute renal infections. Radiol Clin North Am 1996, 34:965-995.
229. Smith RC, Verga M, McCarthy S, et al. Diagnosis of acute flank pain: value of unenhanced helical CT. Am J Roentgenol 1996, 166:97-101.
230. Schreyer HH, Uggowitzer MM, Ruppert-Kohlmayr A Helical CT of the urinary organs. Eur Radiol 2002, 12:575-591.
231. Penfield JG, Reilly RF What nephrologists need to know about gadolinium. Nat Clin Pract Nephrol 2007, 3:654-668.
232. Marks SD, Gordon I, Tullus K Imaging in childhood urinary tract infections: time to reduce investigations. Pediatr Nephrol 2008, 23:9-17.
233. Baumer JH, Jones RW Urinary tract infection in children, National Institute for Health and Clinical Excellence. Arch Dis Child Educ Pract Ed 2007, 92:189-192.
234. Peters CA, Skoog SJ, Arant BS, et al. Summary of the AUA Guideline on Management of Primary Vesicoureteral Reflux in Children. J Urol 2010, 184:1134-1144.
235. Pennesi M, Travan L, Peratoner L, et al. North East Italy Prophylaxis in VUR study group. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics 2008, 121:e1489-e1494.
236. Schwab CW, Wu HY, Selman H, et al. Spontaneous resolution of vesicoureteral reflux: a 15-year perspective. J Urol 2002, 168:2594-2599.
237. Garin EH, Olavarria F, Garcia Nieto V, et al. Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics 2006, 117:626-632.
238. Moorthy I, Easty M, McHugh K, et al. The presence of vesicoureteric reflux does not identify a population at risk for renal scarring following a first urinary tract infection. Arch Dis Child 2005, 90:733-736.
239. Rosenberg AR, Rossleigh MA, Brydon MP, et al. Evaluation of acute urinary tract infection in children by dimercaptosuccinic acid scintigraphy: a prospective study. J Urol 1992, 148:1746-1749.
240. Hoberman A, Charron M, Hickey RW, et al. Imaging studies after a first febrile urinary tract infection in young children. N Engl J Med 2003, 348:195-202.
241. Levison ME, Kaye D Treatment of complicated urinary tract infections with an emphasis on drug-resistant gram-negative uropathogens. Curr Infect Dis Rep 2013, 15:109-115.
242. Nicolle L Complicated urinary tract infection in adults. Can J Infect Dis Med Microbiol 2005, 16:349-360.
243. Hilbert DW, Paulish-Miller TE, Tan CK, et al. Clinical Escherichia coli isolates utilize alpha-hemolysin to inhibit in vitro epithelial cytokine production. Microbes Infect 2012, 14:628-638.
244. Spurbeck RR, Stapleton AE, Johnson JR, et al. Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: contribution of ygi and yad fimbriae. Infect Immun 2011, 79:4753-4763.
245. Loughman JA, Hunstad DA Attenuation of human neutrophil migration and function by uropathogenic bacteria. Microbes Infect 2011, 13:555-565.
246. Floyd RV, Upton M, Hultgren SJ, et al. Escherichia coli-mediated impairment of ureteric contractility is uropathogenic E. coli specific. J Infect Dis 2012, 206:1589-1596.
247. Nielubowicz GR, Mobley HL Host-pathogen interactions in urinary tract infection. Nat Rev Urol 2010, 7:430-441.
248. Ragnarsdóttir B, Jönsson K, Urbano A, et al. Toll-like receptor 4 promoter polymorphisms: common TLR4 variants may protect against severe urinary tract infection. PLoS One 2010, 5:e10734.
249. Hernández JG, Sundén F, Connolly J, et al. Genetic control of the variable innate immune response to asymptomatic bacteriuria. PLoS One 2011, 6:e28289.
250. Hawn TR, Scholes D, Li SS, et al. Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women. PLoS One 2009, 4:e5990.
251. Billips BK, Forrestal SG, Rycyk MT, et al. Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli. Infect Immun 2007, 75:5353-5360.
252. Ali AS, Townes CL, Hall J, et al. Maintaining a sterile urinary tract: the role of antimicrobial peptides. J Urol 2009, 182:21-28.
253. Czaja CA, Stamm WE, Stapleton AE, et al. Prospective cohort study of microbial and inflammatory events immediately preceding Escherichia coli recurrent urinary tract infection in women. J Infect Dis 2009, 200:528-536.
254. Lundstedt AC, McCarthy S, Gustafsson MC, et al. A genetic basis of susceptibility to acute pyelonephritis. PLoS One 2007, 2:e825.
255. Scholes D, Hawn TR, Roberts PL, et al. Family history and risk of recurrent cystitis and pyelonephritis in women. J Urol 2010, 184:564-569.
256. Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011, 52:e103-e120.
257. Falagas ME, Kastoris AC, Kapaskelis AM, et al. Fosfomcyin for the treatment of multidrug resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect Dis 2010, 10:43-50.
258. Peirano G, Pitout JD Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 2010, 35:316-321.
259. Johnson JR, Johnston B, Connie C, et al. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis 2010, 51:286-294.
260. Gomez R, Gustafson DR, Rosenblagt JR, Patel R Actinobaculum bacteremia: a report of 12 cases. J Clin Microbiol 2011, 49:4311-4313.
261. Zimmerman P, Berlinger L, Liniger B, et al. Actinobaculum schaalii an emerging pediatric pathogen?. BMC Infect Dis 2012, 12:201-216.
262. Lin K, Fajardo K Screening for asymptomatic bacteriuria in adults: evidence for the U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med 2008, 149:W20-W24. U.S. Preventive Services Task Force.
263. Montini G, Tullus K, Hewitt I Febrile urinary tract infections in children. N Engl J Med 2011, 365:239-250.
264. Saadeh SA, Mattoo TK Managing urinary tract infections. Pediatr Nephrol 2011, 26:1967-1976.
265. Mattoo TK Vesicoureteral reflux and reflux nephropathy. Adv Chronic Kidney Dis 2011, 18:348-354.
266. Shaikh N, Ewing AL, Bhatnagar S, Hoberman A Risk of renal scarring in children with a first urinary tract infection: a systematic review. Pediatrics 2010, 126:1084-1091.
267. Hooton TM Uncomplicated urinary tract infection. N Engl J Med 2012, 366:1028-1037.
268. Nicolle LE Update in adult urinary tract infection. Curr Infect Dis Rep 2011, 13:552-560.
269. Foxman B The epidemiology of urinary tract infection. Nat Rev Urol 2010, 7:653-660.
270. Nicolle LE Urinary tract infections in the elderly. Clin Geriatr Med 2009, 25:423-436.
271. Abrutyn E, Mossey J, Berlin JA, et al. Does asymptomatic bacteriuria predict mortality and does antimicrobial treatment reduce mortality in elderly ambulatory women?. Ann Intern Med 1994, 120:827-833.
272. Nicolle L, Bradley S, Colgan R, et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005, 40:643-654.
273. Nicolle LE, Zhanel GG, Harding GK Microbiological outcomes in women with diabetes and untreated asymptomatic bacteriuria. World J Urol 2006, 24:61-65.
274. Warren JW, Abrutyn E, Hebel JR, et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999, 29:745-758.
275. Hooton TM, Roberts PL, Cox ME, et al. Voided midstream urine culture and acute cystitis in premenopausal women. N Engl J Med 2013, 369:1883-1891.
276. Little P, Moore MV, Turner S, et al. Effectiveness of five different approaches in management of urinary tract infection: randomized controlled trial. BMJ 2010, 340:c199.
277. Bleindorn J, Gagyor I, Kochen MM, et al. Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for acute uncomplicated urinary tract infection? Results of a randomized controlled pilot trial. BMC Med 2010, 8:30.
278. Falagas ME, Kotsantis IK, Vouloumanou EK, et al. Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials. J Infect 2009, 58:91-102.
279. Cai T, Mazzoli S, Mondaini F, et al. The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections: to treat or not to treat?. Clin Infect Dis 2012, 55:771-777.
280. Stapleton AE, Au-Yeung M, Hooton TM, et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis 2011, 52:1212-1217.
281. Williams GJ, Hodson EH, Issacs D, et al. Diagnosis and management of urinary tract infection in children. J Paediatr Child Health 2012, 48:296-301.
282. National Institute for Health and Clinical Excellence Urinary Tract Infection in Children 2007, NIC, London. http://guidance.nice.org.uk/CG54.
283. American Urological Association.Clinical guidelines Available at, Accessed Jan. 11, 2013. http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines.cfm?sub=vur2010.
284. Falagas ME, Vouloumanou EK, Togias AG, et al. Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials. J Antimicrob Chemother 2010, 65:1862-1877.
285. Lichtenberger P, Hooton TM Antimicrobial prophylaxis in women with recurrent urinary tract infections. Int J Antimicrob Agents 2011, 38(suppl):36-41.
286. Fisher JF, Sobel JD, Kauffman CA, et al. Candida urinary tract infections-treatment. Clin Infect Dis 2011, 6:S457-S466.
287. Farkash E, Weintraub AY, Sergienko R, et al. Acute antepartum pyelonephritis in pregnancy: a critical analysis of risk factors and outcomes. Eur J Obstet Gynecol Reprod Biol 2012, 162:24-27.
288. Guinto VT, De Guia B, Festin MR, et al. Different antibiotic regimens for treating asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev 2010, 8.
289. Schneeberger C, Geerlings SE, Middleton P, et al. Interventions for preventing recurrent urinary tract infection during pregnancy. Cochrane Database Syst Rev 2012, (11).
290. Gardiner RA, Gwynne RA, Roberts SA Perinephric abscess. BJU Int 2011, 3:20-23.
291. Rajesh A, Jakanani G, Mayer N, et al. Computed tomography findings in xanthogranulomatous pyelonephritis. J Clin Imaging Sci 2011, 1:45.
292. Craig WD, Wagner BJ, Travis MD Pyelonephritis: radiologic-pathologic review. Radiographics 2008, 28:255-277.